Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Recent & Breaking News (TSXV:MPH)

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021

Canada NewsWire April 27, 2022

MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST

PR Newswire April 26, 2022

MEDICURE ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SUCCESSION PLAN

PR Newswire March 23, 2022

Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy

PR Newswire February 22, 2022

Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy

PR Newswire February 9, 2022

Algernon Pharmaceuticals Announces New Chief Financial Officer

GlobeNewswire November 30, 2021

Medicure Reports Financial Results for Quarter Ended September 30, 2021

PR Newswire November 22, 2021

Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans

PR Newswire November 22, 2021

Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint

PR Newswire November 4, 2021

Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021

PR Newswire August 27, 2021

Medicure Announces Grant of Stock Options

PR Newswire July 30, 2021

Medicure Announces Appointment of David Gurvey as Chief Financial Officer

Canada NewsWire June 24, 2021

Medicure Reports Financial Results for Quarter Ended March 31, 2021

Canada NewsWire May 10, 2021

Medicure 2020 Annual and Q1 2021 Results and Conference Call Date

Canada NewsWire May 5, 2021

Medicure Announces Resignation of Chief Financial Officer and Succession Plan

Canada NewsWire April 28, 2021

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020

Canada NewsWire April 20, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021

Canada NewsWire March 29, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021

Canada NewsWire March 8, 2021

Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021

Canada NewsWire February 22, 2021

Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021

Canada NewsWire February 4, 2021